Metraipolis › archive › dc_316634ff541f

Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes — Europe PMC PMID:41053997

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41053997
DOI
10.1111/dom.70164
License (as archived)
solo-consultazione
Archived
2026-11-09T13:21:46.799Z
SHA-256 of the archived text
55a109d37b1c415d124206c9e98eac3f2f2513b5ac83b807297cd21fe5f13001
Stable URL of this page
https://metraipolis.com/documento/dc_316634ff541f

How to cite

Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes — Europe PMC PMID:41053997 — Europe PMC (en), https://europepmc.org/article/MED/41053997 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_316634ff541f (Metraipolis archive dc_316634ff541f, sha256 55a109d37b1c415d124206c9e98eac3f2f2513b5ac83b807297cd21fe5f13001)
BibTeX
@misc{dc316634ff541f,
  title = {Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes — Europe PMC PMID:41053997},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41053997},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_316634ff541f; sha256 55a109d37b1c415d124206c9e98eac3f2f2513b5ac83b807297cd21fe5f13001},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41053997. Agents can read the archived copy with the MCP tool read_document.